KA
MRK icon

Keene & Associates’s Merck MRK Stock Holding History

Keene & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$2.91M Buy
29,240
+2,485
+9% +$256K 2.34% 23
2024
Q3 		$3.04M Buy
26,755
+570
+2% +$67.7K 2.3% 25
2024
Q2 		$3.24M Sell
26,185
-7,205
-22% -$928K 2.64% 21
2024
Q1 		$4.41M Sell
33,390
-999
-3% -$123K 3.29% 2
2023
Q4 		$3.75M Sell
34,389
-358
-1% -$37.2K 3.11% 5
2023
Q3 		$3.58M Buy
34,747
+382
+1% +$41.2K 2.87% 8
2023
Q2 		$3.97M Sell
34,365
-55
-0.2% -$6.25K 3.08% 5
2023
Q1 		$3.66M Sell
34,420
-2,148
-6% -$232K 2.84% 9
2022
Q4 		$4.06M Sell
36,568
-5,017
-12% -$513K 3.62% 4
2022
Q3 		$3.58M Sell
41,585
-535
-1% -$47.8K 3.29% 3
2022
Q2 		$3.84M Sell
42,120
-160
-0.4% -$14.2K 3.59% 1
2022
Q1 		$3.47M Buy
42,280
+3,838
+10% +$303K 2.83% 8
2021
Q4 		$2.95M Buy
+38,442
New +$3.06M 2.55% 19

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Keene & Associates's MRK Position: Q4 2024 in Review

Keene & Associates increased its Merck (MRK) stake by 9.3% in Q4 2024, buying an estimated $256K and bringing the position to 29,240 shares worth $2.91M. The position accounts for 2.34% of the portfolio, ranked #23.

Keene & Associates first reported a position in MRK in Q4 2021 and has held it in 13 quarters since. The position peaked at $4.41M in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Keene & Associates held 29,240 shares of Merck worth $2.91M as of Q4 2024.
  • Keene & Associates bought 2,485 Merck shares in Q4 2024, an estimated $256K.
  • Merck made up 2.34% of Keene & Associates's portfolio in Q4 2024, its #23 holding.
  • Keene & Associates first reported a position in Merck in Q4 2021 and has held it in 13 quarters since.
  • Keene & Associates's Merck position peaked at $4.41M in Q1 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Keene & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.